三和精化(00301.HK)預計年度純利減少約78.7%
格隆匯3月14日丨三和精化(00301.HK)發佈公吿,公司預計截至2021年12月31日止年度錄得公司擁有人應占溢利約人民幣1400萬元,對比截至2020年12月31日止年度公司擁有人應占溢利約人民幣6582萬元減少約78.7%。
減少的主要原因是原材料採購價格上漲。於2021年間,中國國務院進行了重大戰略決策,着力解決國內與國際資源環境問題,實現碳達峯和碳中和目標。此外,國內限制資源供電短缺情況波及十多個省份。集團上游供應商的銷售價格管控對國家政策敏感度高,基於集團原材料佔銷售成本比重顯著,原材料成本上漲會帶來負面影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.